Labcorp unveils direct-to-consumer genetic health panel covering 163 genes and 100+ conditions

Labcorp announced the launch of a new direct-to-consumer test called the Marker by Labcorp Genetic Health Panel.

The panel examines 163 genes to assess risk for more than 100 hereditary conditions, including several cancers, heart disease, and various neurological, muscular and metabolic disorders.

Results also include information on how genetics may affect response to certain medicines and traits linked to athletic performance, and the service pairs testing with counseling from licensed genetic counselors.

Labcorp noted that roughly one in six adults carries an actionable inherited risk, yet most are unaware, and the company says early detection can enable targeted interventions and lifestyle changes.